APA (7th ed.) Citation

Rashid, K., Röder, C., Goumas, F., Egberts, J., & Kalthoff, H. (2021). CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers, 13(21), 5458. https://doi.org/10.3390/cancers13215458

Chicago Style (17th ed.) Citation

Rashid, Khalid, Christian Röder, Freya Goumas, Jan-Hendrik Egberts, and Holger Kalthoff. "CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells." Cancers 13, no. 21 (2021): 5458. https://doi.org/10.3390/cancers13215458.

MLA (9th ed.) Citation

Rashid, Khalid, et al. "CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells." Cancers, vol. 13, no. 21, 2021, p. 5458, https://doi.org/10.3390/cancers13215458.